Generic Name and Formulations:
Carbachol 0.01%; per mL; soln for intraocular inj.
Alcon Laboratories, Inc.
Indications for MIOSTAT:
To obtain miosis during eye surgery. To reduce the intensity of intraocular pressure elevation in the first 24 hours after cataract surgery.
See full labeling. Withdraw contents into a dry sterile syringe and replace the needle with an atraumatic cannula prior to intraocular instillation. Gently instill no more than ½ mL into the anterior chamber; may be instilled before or after securing sutures. Usually within 2–5 mins after application for maximal miosis effects.
For single-dose intraocular use only. Acute cardiac failure. Bronchial asthma. Peptic ulcer. Hyperthyroidism. GI spasm. Urinary tract obstruction. Parkinson's disease. Latex allergy. Pregnancy (Cat.C). Nursing mothers.
Corneal clouding, persistent bullous keratopathy, retinal detachment, postoperative iritis; flushing, sweating, epigastric distress, abdominal cramps, tightness in urinary bladder, headache.
Single-use vial (1.5mL)—12
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder
- How Personalized Hospital Ratings May Drive Patient-Specific Care in the Digital Age